An Australian study has concluded that specific types of defects in vision are associated with increased risk of car crashes.

Researchers from the United Arab Emirates have developed ‘smart’ contact lenses that have both UV-transition and temperature-responsive capabilities.

A potential new strategy for glaucoma cell replacement therapy has been identified by a multidisciplinary team led by researchers at the Schepens Eye Research

Biopharmaceutical company OKYO Pharma Limited has reported positive safety and efficacy results in its Phase 2 trial evaluating the safety and efficacy of OK-101